73 related articles for article (PubMed ID: 24787227)
41. Secreted frizzled-related protein 4 and its implications in cancer and apoptosis.
Pohl S; Scott R; Arfuso F; Perumal V; Dharmarajan A
Tumour Biol; 2015 Jan; 36(1):143-52. PubMed ID: 25501511
[TBL] [Abstract][Full Text] [Related]
42. What will it take to obtain DNA methylation markers for early cervical cancer detection?
Nephew KP
Gynecol Oncol; 2009 Feb; 112(2):291-2. PubMed ID: 19150524
[No Abstract] [Full Text] [Related]
43. Diabetes: SFRP4-a biomarker for islet dysfunction?
Wilson C
Nat Rev Endocrinol; 2013 Feb; 9(2):65. PubMed ID: 23183672
[No Abstract] [Full Text] [Related]
44. Corrigendum to: Ptr1 and ZAR1 immune receptors confer overlapping and distinct bacterial pathogen effector specificities.
New Phytol; 2024 Apr; 242(1):320-322. PubMed ID: 38357992
[No Abstract] [Full Text] [Related]
45. The Relevance of Gender in Tumor-Influencing Epigenetic Traits.
Sarne V; Braunmueller S; Rakob L; Seeboeck R
Epigenomes; 2019 Jan; 3(1):. PubMed ID: 34991275
[TBL] [Abstract][Full Text] [Related]
46. Tumor suppressor role of sFRP‑4 in hepatocellular carcinoma via the Wnt/β‑catenin signaling pathway.
Wu Q; Xu C; Zeng X; Zhang Z; Yang B; Rao Z
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760186
[TBL] [Abstract][Full Text] [Related]
47. FANCF hypomethylation is associated with colorectal cancer in Han Chinese.
Yu H; Pan R; Gao T; Wu D; Ying J; Duan S
Turk J Gastroenterol; 2020 Aug; 31(8):558-565. PubMed ID: 32915143
[TBL] [Abstract][Full Text] [Related]
48. Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion.
Kurmyshkina O; Kovchur P; Schegoleva L; Volkova T
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899940
[TBL] [Abstract][Full Text] [Related]
49. Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function.
Deutschmeyer V; Breuer J; Walesch SK; Sokol AM; Graumann J; Bartkuhn M; Boettger T; Rossbach O; Richter AM
Clin Epigenetics; 2019 Dec; 11(1):182. PubMed ID: 31801617
[TBL] [Abstract][Full Text] [Related]
50. Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta-analysis.
Yu J; Xie Y; Li M; Zhou F; Zhong Z; Liu Y; Wang F; Qi J
Oncol Lett; 2019 Oct; 18(4):3481-3492. PubMed ID: 31516566
[TBL] [Abstract][Full Text] [Related]
51. Systematic prediction of target genes and pathways in cervical cancer from microRNA expression data.
Chen R; Shi YH; Zhang H; Hu JY; Luo Y
Oncol Lett; 2018 Jun; 15(6):9994-10000. PubMed ID: 29928371
[TBL] [Abstract][Full Text] [Related]
52. Antagonizing canonical Wnt signaling pathway by recombinant human sFRP4 purified from E. coli and its implications in cancer therapy.
Ghoshal A; Ghosh SS
Mol Cell Biochem; 2016 Jul; 418(1-2):119-35. PubMed ID: 27334754
[TBL] [Abstract][Full Text] [Related]
53. Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line.
Buchegger K; Ili C; Riquelme I; Letelier P; Corvalán AH; Brebi P; Huang TH; Roa JC
Biol Res; 2016 Jan; 49():5. PubMed ID: 26796959
[TBL] [Abstract][Full Text] [Related]
54. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
Ge C; Wu S; Wang W; Liu Z; Zhang J; Wang Z; Li R; Zhang Z; Li Z; Dong S; Wang Y; Xue Y; Yang J; Tan Q; Wang Z; Song X
Oncotarget; 2015 May; 6(13):10964-77. PubMed ID: 25844602
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of ZAR1 and SFRP4 methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase I.
Brebi P; Hoffstetter R; Andana A; Ili CG; Saavedra K; Viscarra T; Retamal J; Sanchez R; Roa JC
Biomarkers; 2014 May; 19(3):181-8. PubMed ID: 24787227
[TBL] [Abstract][Full Text] [Related]
56. Non-promoter DNA hypermethylation of Zygote Arrest 1 (ZAR1) in neuroblastomas.
Sugito K; Kawashima H; Yoshizawa S; Uekusa S; Hoshi R; Furuya T; Kaneda H; Hosoda T; Konuma N; Masuko T; Ohashi K; Ikeda T; Koshinaga T; Tomita R; Shinojima Y; Fujiwara K; Watanabe T; Held WA; Nagase H
J Pediatr Surg; 2013 Apr; 48(4):782-8. PubMed ID: 23583134
[TBL] [Abstract][Full Text] [Related]
57. Quantitative assessment of DNA methylation for the detection of cervical and endometrial adenocarcinomas in liquid-based cytology specimens.
Kim GE; Kweon SS; Lee JS; Lee JH; Nam JH; Choi C
Anal Quant Cytopathol Histpathol; 2012 Aug; 34(4):195-203. PubMed ID: 23016466
[TBL] [Abstract][Full Text] [Related]
58. Quantitative analysis of the relationship between microRNA‑124a, -34b and -203 gene methylation and cervical oncogenesis.
Botezatu A; Goia-Rusanu CD; Iancu IV; Huica I; Plesa A; Socolov D; Ungureanu C; Anton G
Mol Med Rep; 2011; 4(1):121-8. PubMed ID: 21461574
[TBL] [Abstract][Full Text] [Related]
59. Non-promoter hypermethylation of zygote arrest 1 (ZAR1) in human brain tumors.
Watanabe T; Yachi K; Ohta T; Fukushima T; Yoshino A; Katayama Y; Shinojima Y; Terui T; Nagase H
Brain Tumor Pathol; 2011 Jul; 28(3):199-202. PubMed ID: 21331615
[TBL] [Abstract][Full Text] [Related]
60. The ZAR1 protein in cancer; from epigenetic silencing to functional characterisation and epigenetic therapy of tumour suppressors.
Deutschmeyer VE; Richter AM
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188417. PubMed ID: 32828887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
